Increased expression of long non-coding RNA FIRRE promotes hepatocellular carcinoma by HuR-CyclinD1 axis signaling
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Yuki Haga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Cyclin D1, ELAV-Like Protein 1, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Lottie Caroline Hardy Charitable Trust, National Institutes of Health.
Abstract (Originalsprache)
There is a critical need to understand the disease processes and identify improved therapeutic strategies for hepatocellular carcinoma (HCC). The long noncoding RNAs (lncRNAs) display diverse effects on biological regulations. The aim of this study was to identify a lncRNA as a potential biomarker of HCC and investigate the mechanisms by which the lncRNA promotes HCC progression using human cell lines and in vivo. Using RNA-Seq analysis, we found that lncRNA FIRRE was significantly upregulated in hepatitis C virus (HCV) associated liver tissue and identified that lncRNA FIRRE is significantly upregulated in HCV-associated HCC compared to adjacent non-tumor liver tissue. Further, we observed that FIRRE is significantly upregulated in HCC specimens with other etiologies, suggesting this lncRNA has the potential to serve as an additional biomarker for HCC. Overexpression of FIRRE in hepatocytes induced cell proliferation, colony formation, and xenograft tumor formation as compared to vector-transfected control cells. Using RNA pull-down proteomics, we identified HuR as an interacting partner of FIRRE. We further showed that the FIRRE-HuR axis regulates cyclin D1 expression. Our mechanistic investigation uncovered that FIRRE is associated with an RNA-binding protein HuR for enhancing hepatocyte growth. Together, these findings provide molecular insights into the role of FIRRE in HCC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA.
- Department of Pathology, Saint Louis University, St. Louis, Missouri, USA.
- Department of Surgery, Saint Louis University, St. Louis, Missouri, USA.
- Department of Pathology, Saint Louis University, St. Louis, Missouri, USA. Electronic address: ratna.ray@health.slu.edu.
Förderung
- NIDDK NIH HHS
- Lottie Caroline Hardy Charitable Trust
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Haga, Y., Bandyopadhyay, D., Khatun, M., Tran, E., Steele, R., Banerjee, S., Ray, R., Nazzal, M., & Ray, R. B. (2024). Increased expression of long non-coding RNA FIRRE promotes hepatocellular carcinoma by HuR-CyclinD1 axis signaling. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107247
Vancouver
Haga Y, Bandyopadhyay D, Khatun M, Tran E, Steele R, Banerjee S, et al. Increased expression of long non-coding RNA FIRRE promotes hepatocellular carcinoma by HuR-CyclinD1 axis signaling. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107247
BibTeX
@article{Haga2024,
author = {Haga, Yuki and Bandyopadhyay, Debojyoty and Khatun, Mousumi and Tran, Ellen and Steele, Robert and Banerjee, Sumona and Ray, Ranjit and Nazzal, Mustafa and Ray, Ratna B},
title = {Increased expression of long non-coding RNA FIRRE promotes hepatocellular carcinoma by HuR-CyclinD1 axis signaling},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107247}
}
EUVIMED